greeksoup/ stock research

Universal Health Services (UHS) FY2022 results: revenue $13.4 billion, up 6.0% on the year

Universal Health Services Inc. (UHS) reported revenue of $13.4 billion for fiscal 2022, the year ended 31 December 2022, up 6.0% on the year before. Net income was $676 million, down 31.9%, and diluted earnings per share $9.14. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2023.

Revenue
$13.4 billion
+6.0% on the year
FY2015FY2022
Operating margin
7.5%
10.8% a year earlier
FY2015FY2022
Net income
$676 million
-31.9% on the year
FY2015FY2022
Diluted EPS
$9.14
-22.7% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue13,39912,64211,559+6.0%
Operating income1,0041,3631,358-26.4%
Operating margin7.5%10.8%11.8%
Interest expense12783.7106+51.7%
Pre-tax income8661,2931,252-33.0%
Income tax209306299-31.5%
Effective tax rate24.2%23.6%23.9%
Net income676992944-31.9%
Net margin5.0%7.8%8.2%
Diluted EPS$9.14$11.82$10.99-22.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow9968842,360+12.7%
Capital expenditure734856731-14.2%
Free cash flow26228.01,629+834.6%
Free cash flow margin2.0%0.2%14.1%
Cash from investing-647-914-803
Cash from financing-318-1,069-385
Depreciation and amortisation582533510+9.1%
Share-based compensation85.473.765.8+15.9%
Buybacks8331,221207-31.8%
Dividends paid58.465.917.3-11.3%
Dividend per share$0.80$0.80n/a0.0%
Diluted shares, weighted74m84m86m-11.8%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity5,9216,0906,317-2.8%
Non-controlling interest44.810384.8-56.7%
Redeemable equity4.75.14.6-8.3%
Debt4,8084,1903,856+14.7%
Operating lease liabilities396305278+29.8%
Finance lease liabilities72.576.650.8-5.3%
Other liabilities2,2482,3242,885-3.3%
Total liabilities and equity13,49413,09413,477+3.1%
Fixed assets5,9185,8745,373+0.8%
Goodwill3,9093,9633,883-1.3%
Intangible assets78.181.082.6-3.6%
Cash and equivalents1031151,224-10.8%
Receivables2,0181,7471,729+15.5%
Other assets1,4681,3141,185+11.7%
Total assets13,49413,09413,477+3.1%

10-K for the year ended 31 December 2022, filed 27 February 2023: the filing.